Slides: https://www.andreashandel.com/presentations/
2023-10-11
SC = Seroconversion, TI = Titer Increase (D28/D0), n = individuals, j = Strains.
We sampled from the panel of heterologous strains from UGAFluVac to mimic different labs
The table shows the coefficient of variation for each outcome.
Current method | Proposed method | |
---|---|---|
Magnitude | 0.088 | 0.103 |
Breadth | 0.059 | 0.431 |
Overall strength | 0.083 | 0.081 |
Our new method is worse (more variable)!
Create a universe of 50 possible heterologous strains with varying antigenic distances.
Create 10 lab panels by randomly sampling 9 strains and adding the homologous strain (distance of 0).
For each lab, generate 100 random individuals by simulating flu vaccine response titers from a model that shows linearly reduced response with increasing antigenic distance.
Current method | Proposed method | |
---|---|---|
Magnitude | 0.025 | 0.008 |
Breadth | 0.199 | 0.020 |
Overall strength | 0.155 | 0.007 |
Now our new method is better. Hm…
Current method | Proposed method | |
---|---|---|
Magnitude | 0.028 | 0.033 |
Breadth | 0.290 | 0.316 |
Overall strength | 0.137 | 0.071 |
With censored data, the current method looks artificially good.
There is some evidence that repeat vaccinations leads to reduced vaccine effectiveness (VE).
Bi et al, 2023 medRxiv
No impact other than pre-vaccine antibodies?
Solid: recent vaccination. Open: no vaccination last 3 years. Linderman et al 2020 CSH
Data from the UGA vaccine cohort described earlier.
Data from a U of Rochester vaccine cohort, courtesy of Andrea Sant. See also Moritzky et al 2023 JID.
https://phdcomics.com/
Data from the UGA vaccine cohort described earlier.
Data from a U of Rochester vaccine cohort, courtesy of Andrea Sant. See also Moritzky et al 2023 JID.